[1]
|
Han, M.H., il Ryu, J., Kim, C.H., et al. (2016) Predictive Factors for Recurrence and Clinical Outcomes in Patients with Chronic Subdural Hematoma. Journal of Neurosurgery, 127, 1117-1125.
https://doi.org/10.3171/2016.8.JNS16867
|
[2]
|
Ayub, K. and Yarnell, O.P. (1969) Subdural Haematoma after Whiplash Injury. The Lancet, 294, 237-239.
https://doi.org/10.1016/S0140-6736(69)90005-1
|
[3]
|
Markwalder, T.M. (1981) Chronic Subdural Hematomas: A Review. Journal of Neurosurgery, 54, 637-645.
https://doi.org/10.3171/jns.1981.54.5.0637
|
[4]
|
Inglis, K. (1946) Subdural Haemorrhage, Cysts and False Mem-branes: Illustrating the Influence of Intrinsic Factors in Disease When Development of the Body Is Normal. Brain, 69, 157-194. https://doi.org/10.1093/brain/69.3.157
|
[5]
|
Schwartz, A.B. (1916) The Etiology of Pachymeningitis Hemorrhagica Interna in Infants. American Journal of Diseases of Children, 11, 23-32. https://doi.org/10.1001/archpedi.1916.04110070034004
|
[6]
|
Putnam, T.J. and Cushing, H. (1925) Chronic Sub-dural Hematoma: Its Pathology, Its Relation to Pachymeningitis Hemorrhagica and Its Surgical Treatment. Archives of Surgery, 11, 329-393.
https://doi.org/10.1001/archsurg.1925.01120150002001
|
[7]
|
Edlmann, E., Giorgi-Coll, S., Whitfield, P.C., et al. (2017) Pathophysiology of Chronic Subdural Haematoma: Inflammation, Angiogenesis and Implications for Pharma-cotherapy. Journal of Neuroinflammation, 14, 1-13.
https://doi.org/10.1186/s12974-017-0881-y
|
[8]
|
Nanko, N., Tanikawa, M., Mase, M., et al. (2009) Involvement of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in the Mechanism of Development of Chronic Subdural Hematoma. Neurologia Medico- Chirurgica, 49, 379-385. https://doi.org/10.2176/nmc.49.379
|
[9]
|
Ito, H., Komai, T. and Yamamoto, S. (1978) Fibrinolytic Enzyme in the Lining Walls of Chronic Subdural Hematoma. Jour-nal of Neurosurgery, 48, 197-200. https://doi.org/10.3171/jns.1978.48.2.0197
|
[10]
|
Murakami, H., Hirose, Y., Sa-goh, M., et al. (2002) Why Do Chronic Subdural Hematomas Continue to Grow Slowly and Not Coagulate? Role of Thrombomodulin in the Mechanism. Journal of Neurosurgery, 96, 877-884.
https://doi.org/10.3171/jns.2002.96.5.0877
|
[11]
|
Hohenstein, A., Erber, R., Schilling, L., et al. (2005) Increased mRNA Expression of VEGF within the Hematoma and Imbalance of Angiopoietin-1 and-2 mRNA within the Neomem-branes of Chronic Subdural Hematoma. Journal of Neurotrauma, 22, 518-528. https://doi.org/10.1089/neu.2005.22.518
|
[12]
|
Nakagawa, T., Kodera, T. and Kubota, T. (2000) Expression of Ma-trix Metalloproteinases in the Chronic Subdural Haematoma Membrane. Acta Neurochirurgica, 142, 61-66. https://doi.org/10.1007/s007010050008
|
[13]
|
Kwaan, H.C. (1972) Disorders of Fibrinolysis. Medical Clinics of North America, 56, 163-176.
https://doi.org/10.1016/S0025-7125(16)32432-4
|
[14]
|
Fujisawa, H., Ito, H., Saito, K., et al. (1991) Immunohisto-chemical Localization of Tissue-Type Plasminogen Activator in the Lining Wall of Chronic Subdural Hematoma. Surgical Neurology, 35, 441-445.
https://doi.org/10.1016/0090-3019(91)90177-B
|
[15]
|
Agre, P. (2006) The Aquaporin Water Channels. Proceedings of the American Thoracic Society, 3, 5-13.
https://doi.org/10.1513/pats.200510-109JH
|
[16]
|
Zelenina, M. (2010) Regulation of Brain Aquaporins. Neuro-chemistry International, 57, 468-488.
https://doi.org/10.1016/j.neuint.2010.03.022
|
[17]
|
Nielsen, S., Nagelhus, E.A., Amiry-Moghaddam, M., et al. (1997) Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain. Journal of Neuroscience, 17, 171-180. https://doi.org/10.1523/JNEUROSCI.17-01-00171.1997
|
[18]
|
Basaldella, L., Perin, A., Orvieto, E., et al. (2010) A Preliminary Study of Aquaporin 1 Immunolocalization in Chronic Subdural Hematoma Membranes. Journal of Clinical Neuroscience, 17, 905-907.
https://doi.org/10.1016/j.jocn.2009.11.010
|
[19]
|
Utsuki, S., Oka, H., Kijima, C., et al. (2012) Role of Saireito in Postoperative Chronic Subdural Hematoma Recurrence Prevention. Journal of Traditional Medicines, 29, 137-142.
|
[20]
|
Hori, Y.S., Ebisudani, Y., Aoi, M., et al. (2018) Elevated Serum Fibrinogen Degradation Products on Admission Is a Novel Predictive Factor for Recurrence of Chronic Subdural Hematoma. World Neurosurgery, 118, e753-e757.
https://doi.org/10.1016/j.wneu.2018.07.039
|
[21]
|
宗海亮, 许洪升, 何晓光, 尚明. 慢性硬膜下血肿钻颅术并发症的临床研究[J]. 中国继续医学教育, 2021, 13(7): 150-153.
|
[22]
|
Srivatsan, A., Mohanty, A., Nascimento, F.A., et al. (2019) Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Re-view. World Neurosurgery, 122, 613-619.
https://doi.org/10.1016/j.wneu.2018.11.167
|
[23]
|
Bender, M.B. and Christoff, N. (1974) Nonsurgical Treatment of Subdural Hematomas. Archives of Neurology, 31, 73-79. https://doi.org/10.1001/archneur.1974.00490380021001
|
[24]
|
Pichert, G. and Henn, V. (1987) Conservative Ther-apy of Chronic Subdural Hematomas. Schweizerische Medizinische Wochenschrift, 117, 1856-1862.
|
[25]
|
Sun, T.F.D., Boet, R. and Poon, W.S. (2005) Non-Surgical Primary Treatment of Chronic Subdural Haematoma: Preliminary Results of Using Dexamethasone. British Journal of Neurosurgery, 19, 327-333.
https://doi.org/10.1080/02688690500305332
|
[26]
|
Delgado-López, P.D., Martín-Velasco, V., Castilla-Díez, J.M., et al. (2009) Dexamethasone Treatment in Chronic Subdural Haematoma. Neurocirugia, 20, 346-359. https://doi.org/10.1016/S1130-1473(09)70154-X
|
[27]
|
Dran, G., Berthier, F., Fontaine, D., et al. (2007) Effective-ness of Adjuvant Corticosteroid Therapy for Chronic Subdural Hematoma: A Retrospective Study of 198 Cases. Neu-ro-chirurgie, 53, 477-482.
https://doi.org/10.1016/j.neuchi.2007.09.146
|
[28]
|
Thotakura, A.K. and Marabathina, N.R. (2015) Nonsurgical Treatment of Chronic Subdural Hematoma with Steroids. World Neurosurgery, 84, 1968-1972. https://doi.org/10.1016/j.wneu.2015.08.044
|
[29]
|
Qian, Z., Yang, D., Sun, F., et al. (2017) Risk Factors for Recur-rence of Chronic Subdural Hematoma after Burr Hole Surgery: Potential Protective Role of Dexamethasone. British Journal of Neurosurgery, 31, 84-88.
https://doi.org/10.1080/02688697.2016.1260686
|
[30]
|
Hutchinson, P.J., Edlmann, E., Bulters, D., et al. (2020) Trial of Dexamethasone for Chronic Subdural Hematoma. New England Journal of Medicine, 383, 2616-2627. https://doi.org/10.1056/NEJMoa2020473
|
[31]
|
Wang, X., Song, J., He, Q. and You, C. (2021) Pharmacological Treatment in the Management of Chronic Subdural Hematoma. Frontiers in Aging Neuroscience, 13, Article ID: 684501. https://doi.org/10.3389/fnagi.2021.684501
|
[32]
|
Berghauser Pont, L.M.E., Dirven, C.M.F., Dippel, D.W.J., et al. (2012) The Role of Corticosteroids in the Management of Chronic Subdural Hematoma: A Systematic Review. European Journal of Neurology, 19, 1397-1403.
https://doi.org/10.1111/j.1468-1331.2012.03768.x
|
[33]
|
Youssef, S., Stüve, O., Patarroyo, J.C., et al. (2002) The HMG-CoA Reductase Inhibitor, Atorvastatin, Promotes a Th2 Bias and Reverses Paralysis in Central Nervous System Autoimmune Disease. Nature, 420, 78-84.
https://doi.org/10.1038/nature01158
|
[34]
|
Wang, B., Sun, L., Tian, Y., et al. (2012) Effects of Atorvastatin in the Regulation of Circulating EPCs and Angiogenesis in Traumatic Brain Injury in Rats. Journal of the Neurological Scienc-es, 319, 117-123.
https://doi.org/10.1016/j.jns.2012.04.015
|
[35]
|
Li, Z., Wang, B., Kan, Z., et al. (2012) Progesterone Increases Cir-culating Endothelial Progenitor Cells and Induces Neural Regeneration after Traumatic Brain Injury in Aged Rats. Jour-nal of Neurotrauma, 29, 343-353.
https://doi.org/10.1089/neu.2011.1807
|
[36]
|
Araújo, F.A., Rocha, M.A., Mendes, J.B., et al. (2010) Atorvastatin Inhibits Inflammatory Angiogenesis in Mice through Down Regulation of VEGF, TNF-α and TGF-β1. Biomedicine & Pharmacotherapy, 64, 29-34.
https://doi.org/10.1016/j.biopha.2009.03.003
|
[37]
|
Jiang, R., Zhao, S., Wang, R., et al. (2018) Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized Clinical Trial. JAMA Neurology, 75, 1338-1346.
https://doi.org/10.1001/jamaneurol.2018.2030
|
[38]
|
Logan, J.W. (1990) Diet and Free Radicals in Cot Death. New Zealand Medical Journal, 103, 592.
|
[39]
|
Coates, D. (2003) The Angiotensin Converting Enzyme (ACE). The Interna-tional Journal of Biochemistry & Cell Biology, 35, 769-773. https://doi.org/10.1001/jamaneurol.2018.2030
|
[40]
|
Ito, H., Yamamoto, S., Komai, T., et al. (1976) Role of Local Hyperfibrinolysis in the Etiology of Chronic Subdural Hema-toma. Journal of Neurosurgery, 45, 26-31. https://doi.org/10.3171/jns.1976.45.1.0026
|
[41]
|
Weigel, R., Hohen-stein, A., Schlickum, L., et al. (2007) Angiotensin Converting Enzyme Inhibition for Arterial Hypertension Reduces the Risk of Recurrence in Patients with Chronic Subdural Hematoma Possibly by an Antiangiogenic Mechanism. Neurosur-gery, 61, 788-792. https://doi.org/10.3171/jns.1976.45.1.0026
|
[42]
|
Neidert, M.C., Schmidt, T., Mitova, T., et al. (2016) Preoperative Angiotensin Converting Enzyme Inhibitor Usage in Patients with Chronic Subdural Hematoma: As-sociations with Initial Presentation and Clinical Outcome. Journal of Clinical Neuroscience, 28, 82-86. https://doi.org/10.1016/j.jocn.2015.09.022
|
[43]
|
Poulsen, F.R., Munthe, S., Soe, M., et al. (2014) Perindopril and Residual Chronicsubdural Hematoma Volumes Six Weeks after Burr Hole Surgery: A Randomized Trial. Clinical Neu-rology and Neurosurgery, 123, 4-8.
https://doi.org/10.1016/j.clineuro.2014.05.003
|
[44]
|
李逢佳, 李强, 杨红. 钻孔引流术加尿激酶治疗慢性硬膜下血肿96例分析[J]. 中国误诊学杂志, 2010, 10(34): 8472.
|
[45]
|
王安睿, 庄永辉, 戴成国, 等. 微创引流尿激酶血肿腔注射治疗慢性硬膜下血肿66例临床分析[J]. 昆明医学院学报, 2011, 32(9): 57-59.
|
[46]
|
Kostis, W.J., Shetty, M., Chowdhury, Y.S., et al. (2018) ACE Inhibitor-Induced Angioedema: A Review. Current Hypertension Reports, 20, 1-7. https://doi.org/10.1007/s11906-018-0859-x
|
[47]
|
杨舟山, 蔡恩源. 单纯钻孔引流法与钻孔尿激酶注入引流法治疗慢性硬膜下血肿的效果比较[J]. 中国处方药, 2015, 13(1): 106.
|
[48]
|
王进进, 施辉, 董文胜, 樊拥军, 朱家球, 邵世珂. 微创钻孔引流联合尿激酶和阿托伐他汀对慢性硬膜下血肿患者术后神经功能及复发率的影响[J]. 脑与神经疾病杂志, 2021, 29(4): 222-227.
|
[49]
|
王亚飞, 王国伟, 张轩宇, 崔政, 郑虎林, 霍龙伟. 微创硬通道钻孔不冲洗、尿激酶溶解引流联合口服阿托伐他汀治疗慢性硬膜下血肿的临床研究[J]. 川北医学院学报, 2020, 35(5): 898-901.
|